Agilon Health (NYSE:AGL) Shares Down 4.5% – Here’s Why

Agilon Health, Inc. (NYSE:AGL) dropped 4.5% on Wednesday . The company traded as low as $81.55 and last traded at $84.2750. Approximately 56,045 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 365,220 shares. The stock had previously closed at $88.20.

Analysts Set New Price Targets

AGL has been the topic of a number of analyst reports. Weiss Ratings raised shares of Agilon Health from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, May 12th. Benchmark upped their target price on shares of Agilon Health to $13.00 and gave the company a “buy” rating in a research note on Thursday, April 2nd. Barclays lowered their target price on shares of Agilon Health from $25.00 to $12.50 and set an “underweight” rating on the stock in a research note on Friday, February 27th. Jefferies Financial Group raised shares of Agilon Health from a “hold” rating to a “buy” rating and upped their target price for the company from $27.50 to $48.00 in a research note on Thursday, May 7th. Finally, Deutsche Bank Aktiengesellschaft raised shares of Agilon Health from a “hold” rating to a “buy” rating and upped their target price for the company from $33.00 to $49.00 in a research note on Thursday, May 7th. Five analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $45.05.

Agilon Health Trading Down 8.6%

The company has a 50-day simple moving average of $28.18 and a 200-day simple moving average of $21.07. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. The stock has a market cap of $1.34 billion, a P/E ratio of -3.73 and a beta of 2.29.

Agilon Health (NYSE:AGL) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.38 billion. On average, sell-side analysts forecast that Agilon Health, Inc. will post -4.17 EPS for the current fiscal year.

Hedge Funds Weigh In On Agilon Health

Large investors have recently modified their holdings of the stock. CenterBook Partners LP lifted its position in shares of Agilon Health by 492.4% during the third quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock worth $11,771,000 after purchasing an additional 9,499,012 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Agilon Health by 209.5% during the third quarter. JPMorgan Chase & Co. now owns 2,105,297 shares of the company’s stock worth $2,168,000 after purchasing an additional 1,425,052 shares in the last quarter. Pallas Capital Advisors LLC acquired a new position in shares of Agilon Health during the fourth quarter worth approximately $59,000. Quantbot Technologies LP acquired a new position in shares of Agilon Health during the third quarter worth approximately $381,000. Finally, Symphony Financial Services Inc. lifted its position in shares of Agilon Health by 51.6% during the third quarter. Symphony Financial Services Inc. now owns 47,000 shares of the company’s stock worth $48,000 after purchasing an additional 16,000 shares in the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.